J.P. Morgan Private Capital Closes Inaugural Life Sciences Fund Above Target

J.P. Morgan Private Capital has successfully concluded fundraising for its inaugural Life Sciences Private Capital Fund I, surpassing its $500 million target. Led by Chief Investment Officer Stephen Squinto, Ph.D., and Managing Partner Gaurav Gupta, M.D., M.S.E., the fund garnered robust backing from institutional allocators, strategic corporate partners, family offices, and high net worth individuals globally, alongside support from JPMorgan Chase & Co. This achievement underscores strong investor confidence in J.P. Morgan's venture capital and growth equity capabilities within the life sciences sector.